Soleno Therapeutics (SLNO) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.10% |
| Dec 31, 2025 | 96.35% |
| Sep 30, 2025 | 92.93% |
| Jun 30, 2025 | 95.34% |
| Mar 31, 2025 | 106.39% |
| Dec 31, 2024 | 170.89% |
| Sep 30, 2024 | 226.30% |
| Jun 30, 2024 | 100.68% |
| Mar 31, 2024 | 91.85% |
| Dec 31, 2023 | 30.16% |
| Sep 30, 2023 | 56.96% |
| Jun 30, 2023 | 43.34% |
| Mar 31, 2023 | 13.10% |
| Dec 31, 2022 | 34.24% |
| Sep 30, 2022 | 24.76% |
| Jun 30, 2022 | 5.21% |
| Mar 31, 2022 | 28.33% |
| Dec 31, 2021 | 7.26% |
| Sep 30, 2021 | 34.48% |
| Jun 30, 2021 | 31.49% |
| Mar 31, 2021 | 51.77% |
| Dec 31, 2020 | 14.89% |
| Sep 30, 2020 | 21.03% |
| Jun 30, 2020 | 11.15% |
| Mar 31, 2020 | -0.45% |
| Dec 31, 2019 | -8.86% |
| Sep 30, 2019 | 98.22% |
| Jun 30, 2019 | 113.15% |
| Mar 31, 2019 | 86.47% |
| Dec 31, 2018 | 172.24% |